 | Up a level |
Journal Article
Harbeck, Nadia, Schneeweiss, Andreas, Thuss-Patience, Peter, Miller, Kurt, Garbe, Claus 
ORCID: 0000-0001-8530-780X, Griesinger, Frank, Eberhardt, Wilfried E. E., Klussmann, Jens P., Wollenberg, Barbara, Grimm, Marc-Oliver, Zander, Thomas and Lueftner, Diana
(2021).
Neoadjuvant and adjuvant end-points in health technology assessment in oncology.
Eur. J. Cancer, 147.
S. 40 - 51.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
Kreft, Sophia, Gesierich, Anja, Eigentler, Thomas, Franklin, Cindy, Valpione, Sara, Ugurel, Selma, Utikal, Jochen, Haferkamp, Sebastian, Blank, Christian, Larkin, James ORCID: 0000-0001-5569-9523, Garbe, Claus ORCID: 0000-0001-8530-780X, Schadendorf, Dirk, Lorigan, Paul ORCID: 0000-0002-8875-2164 and Schilling, Bastian
(2019).
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma.
Eur. J. Cancer, 116.
S. 207 - 216.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
Weide, Benjamin, Martens, Alexander, Hassel, Jessica C., Berking, Carola, Postow, Michael A., Bisschop, Kees, Simeone, Ester, Mangana, Johanna, Schilling, Bastian ORCID: 0000-0001-8859-4103, Di Giacomo, Anna Maria, Brenner, Nicole, Kaehler, Katharina, Heinzerling, Lucie, Gutzmer, Ralf, Bender, Armin, Gebhardt, Christoffer ORCID: 0000-0001-7090-9584, Romano, Emanuela, Meier, Friedegund, Martus, Peter, Maio, Michele ORCID: 0000-0002-0323-6321, Blank, Christian, Schadendorf, Dirk, Dummer, Reinhard, Ascierto, Paolo A., Hospers, Geke, Garbe, Claus ORCID: 0000-0001-8530-780X and Wolchok, Jedd D.
(2016).
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab.
Clin. Cancer Res., 22 (22).
S. 5487 - 5497.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1557-3265
Leiter, Ulrike ORCID: 0000-0002-8019-1577, Stadler, Rudolf, Mauch, Cornelia, Hohenberger, Werner, Brockmeyer, Norbert, Berking, Carola, Sunderkoetter, Cord, Kaatz, Martin, Schulte, Klaus-Werner, Lehmann, Percy, Vogt, Thomas, Ulrich, Jens, Herbst, Rudolf, Gehring, Wolfgang, Simon, Jan-Christoph, Keim, Ulrike, Martus, Peter and Garbe, Claus ORCID: 0000-0001-8530-780X
(2016).
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
Lancet Oncol., 17 (6).
S. 757 - 768.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
Garbe, Claus ORCID: 0000-0001-8530-780X, Eigentler, Thomas K., Bauer, Juergen, Bloedorn-Schlicht, Norbert, Cerroni, Lorenzo, Fend, Falko, Hantschke, Markus, Kurschat, Peter, Kutzner, Heinz, Metze, Dieter, Mielke, Volker, Pressler, Harald, Reusch, Michael, Reusch, Ursula, Stadler, Rudolf, Tronnier, Michael, Yazdi, Amir and Metzler, Gisela
(2016).
Mitotic rate in primary melanoma: interobserver and intraobserver reliability, analyzed using H&E sections and immunohistochemistry.
J. Dtsch. Dermatol. Ges., 14 (9).
S. 910 - 916.
HOBOKEN:
WILEY.
ISSN 1610-0387
Garbe, Claus ORCID: 0000-0001-8530-780X, Eigentler, Thomas K., Bauer, Juergen, Bloedorn-Schlicht, Norbert, Fend, Falko, Hantschke, Markus, Kurschat, Peter, Kutzner, Heinz, Metze, Dieter, Pressler, Harald, Reusch, Michael, Roecken, Martin, Stadler, Rudolf, Tronnier, Michael, Yazdi, Amir and Metzler, Gisela
(2011).
Histopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practice.
J. Dtsch. Dermatol. Ges., 9 (9).
S. 690 - 700.
HOBOKEN:
WILEY.
ISSN 1610-0387